Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Transformative Robotic Platform Advances Spinal Surgery

By HospiMedica International staff writers
Posted on 28 Jul 2016
A novel surgical guidance system combines analytical tools, multiple-source data, precision guidance, optical tracking, intra-op verification, and connectivity technologies.

The Mazor X provides surgical assurance via three main coordinated processes. More...
The first is a suite of software-based tools designed to pre-operatively assess spinal alignment and implement full surgical planning, facilitating a total patient treatment strategy. A key component of the Pre-Op Analytics component is the X-Align module, a combination of biomechanical logic and virtual surgical tools with computerized alignment calculations, intended to streamline the process of creating a holistic alignment plan for each patient.

The second component is Intra-Operative Guidance, which utilizes precision mechanics and a bed-attached, bone-mounted surgical arm to guide surgical tools and synergistic implants according to the Pre-Op Analytics to confirm predictable execution of the surgical plan. The third component is Real-Time 3D Verification, which uses fluoroscopy, visual tracking, or intraoperative imaging systems to confirm execution and reconciliation of the surgical plan. The Mazor X robotic platform is a product of Mazor Robotics (Caesarea, Israel).

“Our pioneering experience in guidance technology, which has been used by hundreds of surgeons to place over 100,000 guided spine implants, has been leveraged in the development of the Mazor X system,” said Ori Hadomi, CEO of Mazor Robotics. “Following our recently formed partnership with Medtronic and the increased market access it provides us, the launch of the Mazor X positions us for accelerated growth and long term leadership in the spine market.”

Mazor entered into two strategic agreements with Medtronic (Dublin, Ireland) in May 2016. The first agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones (such as the unveiling of the Mazor X system), potential global distribution of certain Mazor products. Following the unveiling, Medtronic ordered 15 Mazor X systems for USD 20 million. The second agreement is for an equity investment by Medtronic in Mazor.

Related Links:
Mazor Robotics
Medtronic

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.